1. Benirschke K, Driscoll SG. Benirschke K, Driscoll SG, editors. Maternal floor infarction. Pathology of the human placenta. 1967. New York (NY): Springer-Verlag;328–330.
2. Benirschke K, Kaufmann SL. Pathology of the human placenta. J Perinatol. 1995. 15:245–250.
3. Andres RL, Kuyper W, Resnik R, Piacquadio KM, Benirschke K. The association of maternal floor infarction of the placenta with adverse perinatal outcome. Am J Obstet Gynecol. 1990. 163:935–938.
4. Mandsager NT, Bendon R, Mostello D, Rosenn B, Miodovnik M, Siddiqi TA. Maternal floor infarction of the placenta: prenatal diagnosis and clinical significance. Obstet Gynecol. 1994. 83:750–754.
5. Vernof KK, Benirschke K, Kephart GM, Wasmoen TL, Gleich GJ. Maternal floor infarction: relationship to X cells, major basic protein, and adverse perinatal outcome. Am J Obstet Gynecol. 1992. 167:1355–1363.
6. Bane AL, Gillan JE. Massive perivillous fibrinoid causing recurrent placental failure. BJOG. 2003. 110:292–295.
7. Adams-Chapman I, Vaucher YE, Bejar RF, Benirschke K, Baergen RN, Moore TR. Maternal floor infarction of the placenta: association with central nervous system injury and adverse neurodevelopmental outcome. J Perinatol. 2002. 22:236–241.
8. Bendon RW, Hommel AB. Maternal floor infarction in autoimmune disease: two cases. Pediatr Pathol Lab Med. 1996. 16:293–297.
9. Gersell DJ. Chronic villitis, chronic chorioamnionitis, and maternal floor infarction. Semin Diagn Pathol. 1993. 10:251–266.
10. Robb JA, Benirschke K, Mannino F, Voland J. Intrauterine latent herpes simplex virus infection: II. Latent neonatal infection. Hum Pathol. 1986. 17:1210–1217.
11. Jauniaux E, Campbell S. Ultrasonographic assessment of placental abnormalities. Am J Obstet Gynecol. 1990. 163:1650–1658.
12. Katzman PJ, Genest DR. Maternal floor infarction and massive perivillous fibrin deposition: histological definitions, association with intrauterine fetal growth restriction, and risk of recurrence. Pediatr Dev Pathol. 2002. 5:159–164.